Clinton Health Access Initiative (CHAI) publication
CHAI released the second edition of its Triple Elimination Series. These market memos examine the diagnostic landscape for preventing vertical transmission of HIV, syphilis, and hepatitis B (HBV). This edition focuses on integrated screening in antenatal care, assessing the emerging market for triple HIV/syphilis/HBV combination tests and modeling market potential under different pricing and financing scenarios, drawing on implementation experience across 16 countries.
Read more about the publication here.
Access ‘Integrated Screening Market Memo | March 2026′ here.
Source : CHAI
Related HIV and Co-Infections News
-
Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.